title: Five-year follow-up of a bipolar steroid-eluting ventricular pacing lead.
abstract: Steroid-eluting pacing leads are known to attenuate the threshold peaking early after implantation. Long-term performance, however, is not yet settled. The lead design tested in this prospective study combines a 5.8-mm2 tip of microporous platinum-iridium with elution of 1.0 mg of dexamethasone sodium phosphate and tines for passive fixation (model 5024, Medtronic Inc.). In 50 patients (mean age 69 +/- 10 years), the electrode was implanted in the right ventricular apex. Follow-up was performed on days 0, 2, 5, 10, 28, 90, 180 and every 6 months thereafter for 5-years postimplant. At each visit, pacing thresholds were determined as pulse duration (ms) at 1.0 V and as the minimum charge (microC) delivered for capture. Lead impedance (omega) was telemetered at 2.5 V-0.50 ms, and sensing thresholds (mV) were measured in triplicate using the automatic sensing threshold algorithm of the pacemaker implanted (model 294-03, Intermedics Inc.). On the day of implantation, mean values were 0.10 +/- 0.03 ms, 0.12 +/- 0.03 microC, 758 +/- 131 omega, and 13.1 +/- 1.8 mV, respectively. Beyond 1-year postimplant, pacing thresholds did not vary significantly. Sensing thresholds and lead impedance values were stable during long-term follow-up. Five years after implantation, mean values were 0.23 +/- 0.11 ms, 0.24 +/- 0.07 microC, 670 +/- 139 omega, and 11.6 +/- 3.1 mV for pulse width and charge threshold, lead impedance, and sensing threshold, respectively, and all leads captured at 1.0 V with the longest pulse duration available (1.50 ms). It is concluded that the bipolar steroid-eluting tined ventricular lead showed stable stimulation thresholds, lead impedance values, and sensing thresholds for 5 years after implantation.
authors.affiliation: Medizinische Universitätsklinik, Homburg/Saar, Germany.
authors.forename: B
authors.initials: B
authors.lastname: Schwaab
authors.forename: G
authors.initials: G
authors.lastname: Fröhlig
authors.forename: M
authors.initials: M
authors.lastname: Berg
authors.forename: H
authors.initials: H
authors.lastname: Schwerdt
authors.forename: H
authors.initials: H
authors.lastname: Schieffer
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D020099:Coated Materials, Biocompatible; D003907:Dexamethasone; D004567:Electrodes, Implanted; D005500:Follow-Up Studies; D005938:Glucocorticoids; D006801:Humans; D008875:Middle Aged; D010138:Pacemaker, Artificial; D011446:Prospective Studies; D017180:Tachycardia, Ventricular / Q000628:therapy*
chemical_list: D020099:Coated Materials, Biocompatible; D005938:Glucocorticoids; D003907:Dexamethasone